T5O0 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
bioXXmed AG is a biotechnology company, which engages in the research and development of therapies to treat cause of diseases. The company provides treatment options in dermatology, cardiology and angiology, urology, and oncology. Its products and pipeline include DermaPro, CardioClean, Cancer T17-n, and Utisept. The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
T5O0 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company